Breaking News - The Fly

Open Search

REGN

Regeneron

$

()

Regeneron price target raised by $10 at BofA, here's why

REGN

4/12/2024 - 07:00am

RBC sees buying opportunity following Regeneron's 'overdone DOJ downside'

REGN

4/11/2024 - 11:58am

DOJ files false claims act complaint against Regeneron over drug pricing

REGN

4/10/2024 - 16:26pm

Regeneron presents pivotal data from Phase 1/2 LINKER-MM1 trial of linvoseltamab

REGN

4/7/2024 - 16:49pm

Regeneron receives CRL from FDA on odronextamab BLA

REGN

3/25/2024 - 07:02am

Regeneron price target raised by $11 at Morgan Stanley, here's why

REGN

3/13/2024 - 07:09am

Oracle, Dollar General upgraded: Wall Street's top analyst calls

ORCL , DG , LUV

…

3/12/2024 - 09:51am

Regeneron initiated with bullish view at Bernstein, here's why

REGN

3/11/2024 - 16:11pm

Regeneron says FDA has extended approval of Praluent

REGN

3/11/2024 - 07:37am

Regeneron published one-year results from PULSAR, PHOTON, met primary endpoint

REGN

3/8/2024 - 07:06am

2seventy bio: Close of asset sale to Regeneron seen in 1H24

TSVT , REGN

3/5/2024 - 07:28am

Regeneron price target raised by $88 at RBC Capital, here's why

REGN

2/27/2024 - 08:34am

Regeneron, Sanofi announce FDA acceptance for priority review of Dupixent sBLA

REGN , SNY

2/23/2024 - 05:16am

Regeneron sees FY24 adjusted EPS $1.42-$1.49, consensus $1.77

REGN

2/21/2024 - 07:35am

Regeneron announces U.S. FDA accepted priority review for BLA for linvoseltamab

REGN

2/21/2024 - 07:18am